Lori Valigra

Grassroots innovation is taking hold again, as the US moves to reassert its dominance in technology products.

A week before Science|Business brings together experts from Europe to discuss personalised medicine here, we look at what’s happening in the US.

Karl Tryggvason, former Dean of Research at Karolinska, admits a ‘mistake’ but tells Science|Business it wasn’t a sacking offence.

The President of the Karolinska Instituet, Harriet Wallberg-Henriksson, has been forced to dismiss a key figure after uncovering undue influence in allocating funds.

A US university has drawn up a standard, “one-size-fits-most” license fee scheme. It aims to save time, but is the industry ready for it?

To Riccardo Pietrabissa, ACES Bridge Award winner for tech transfer and innovation, money is a means to an end, not an end in itself.

Federal and state regulatory changes have opened up new funding and cell lines for stem cell research in the United States.

Venture capitalists are once again taking a shine to Cleantech, emboldened by the highly successful IPO of a battery company and huge amounts of stimulus funding.

About a seventh of the $787 billion US economic stimulus package is targeted at innovation, but can it make a difference soon enough?

There’s a lot of money up for grabs in the US to those with the persistence to find the specific part of the innovation stimulus that applies to them.